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           During B cell development, the near random 
nature of the VDJ recombination process leads 
to the unavoidable production of self-reactive 
antibodies. In fact, studies in humans have dem-
onstrated that many if not most newly gener-
ated B cells are autoreactive (  1  ). Extensive 
studies of self-tolerant B cells in transgenic mouse 
models have revealed the complicated systems 
of B cell selection used to avoid autoimmunity. 
Current models suggest that B cells expressing 
a transgenic surface Ig that binds DNA or pro-
tein autoantigens fi  rst attempt to alter the B cell 
receptor (BCR) by further variable gene rear-
rangement using   “  receptor editing  ”   (  2, 3  ). If 
receptor editing is unsuccessful, then the of-
fending B cell may be eliminated by clonal de-
letion (  4, 5  ) or it may enter maturity but with 
reduced or altered function so that it no longer 
reacts to the self-antigens, which is referred to 
as clonal anergy (  6  –  8  ). In this paper, we de-
scribe a human B cell population that is aner-
gic. Clonal anergy was fi  rst conceived by Nossal 
and Pike in 1980 (  6  ) to explain why injection 
of neonatal mice with high dosages of an anti-
gen induced deletion of the specifi  c B cells, 
whereas lesser dosages allowed retention of the 
specifi  c B cells, but the cells were incapable of 
becoming antibody-secreting cells. In 1988, 
Goodnow et al. (  8  ) demonstrated and charac-
terized B cell anergy in vivo using the MD4/
ML5 transgenic mouse model in which all B cells 
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  Self-reactive B cells not controlled by receptor editing or clonal deletion may become 
anergic. We report that fully mature human B cells negative for surface IgM and retaining 
only IgD are autoreactive and functionally attenuated (referred to as naive IgD  +  IgM        
B cells [B  ND  ]). These B  ND   cells typically make up 2.5% of B cells in the peripheral blood, have 
antibody variable region genes in germline (unmutated) confi  guration, and, by all current 
measures, are fully mature. Analysis of 95 recombinant antibodies expressed from the 
variable genes of single B  ND   cells demonstrated that they are predominantly autoreactive, 
binding to HEp-2 cell antigens and DNA. Upon B cell receptor cross-linkage, B  ND   cells have 
a reduced capacity to mobilize intracellular calcium or phosphorylate tyrosines, demon-
strating that they are anergic. However, intense stimulation causes B  ND  cells to fully re-
spond, suggesting that these cells could be the precursors of autoantibody secreting plasma 
cells in autoimmune diseases such as systemic lupus erythematosus or rheumatoid arthritis. 
This is the fi  rst identifi  cation of a distinct mature human B cell subset that is naturally 
autoreactive and controlled by the tolerizing mechanism of functional anergy. 
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precursors that become high-affi   nity autoreactive B cells in 
diseases such as lupus or rheumatoid arthritis. The functional 
characterization of naturally autoreactive and anergic B cells 
herein is a critical step toward understanding and treating B 
cell mediated autoimmune pathology. 
    RESULTS   
  IgD  +  IgM  -   naive B cells from healthy humans express 
predominantly self-reactive BCRs 
  In transgenic mouse models of tolerance, B cells that predomi-
nantly express IgD isotype BCRs with low levels of surface 
IgM are anergic (  9  ). We hypothesized that IgD  +  IgM       CD27        
naive B cells of healthy humans (  Fig. 1  ) might also be pre-
dominantly autoreactive and anergic.   We therefore expressed 
recombinant monoclonal antibodies from isolated single B cells 
to test the specifi  city of naive B cell fractions (CD27       ) that 
were IgD  +  IgM  +   (true naive) versus IgD  +  IgM        B  ND   cells. B  ND   
cells made up 1  –  10% (typically 2.5   ±   0.716%, SEM) of the 
naive B cells of 40 healthy adult blood donors (  Fig. 1  ). Single 
B cells were sorted by fl  ow cytometry into 96-well plates and 
amplifi  ed by multiplex single-cell RT-PCR to identify and 
clone the Ig heavy and light chain genes from a random as-
sortment of B cells. To ensure that functional transcripts were 
cloned, RT-PCR primers were targeted to the variable gene 
leader sequences and to the respective constant region exons 
(C    , C    , C    , or C    ). The variable genes were then cloned 
into expression vectors and expressed with IgG and C     or 
C     constant regions in the 293A human cell line (  1, 25, 27  ). 
  The production of antibodies that react to dsDNA are 
generally diagnostic of a pathological state in systemic lupus 
erythematosus (SLE) and other autoimmune diseases (  28  –  30  ). 
B  ND   cells produced anti-DNA reactivity nearly fourfold more 
were self-specifi  c to the neoself antigen hen egg lysozyme 
(HEL), and so cells surviving to maturity became anergic, hav-
ing reduced surface BCR density, reduced proliferation and 
antibody secretion, and reduced Ca  2+   fl  ux and tyrosine phos-
phorylation responses (  9  –  11  ). 
  The level and form of tolerance induction and the deci-
sion between anergic states or deletion is dependent on anti-
gen form, specifi  city, and location of encounter. For example, 
soluble forms of the HEL (neoself) antigen allow survival of 
anti-HEL (autoreactive) but anergic B cells, whereas mem-
brane-conjugated forms of HEL induce extensive deletion of 
HEL-specifi  c B cells (  12  ). It has recently been demonstrated 
that in the HEL model of anergy, the B cells are arrested at the 
immature transitional 3 (T3) stage of B cell development (  13  ). 
In fact, it appears that all T3 B cells are naturally anergic even 
if the specifi  city is unknown (  13, 14  ). Other levels of B cell 
functional inactivation or anergy vary depending on the par-
ticular autoantigen specifi  city of the transgenic mouse model 
(for review see reference   15  ). Antiinsulin B cells maintain nor-
mal levels of BCR signaling, such as calcium mobilization, but 
are attenuated for T cell  –  dependent responses, proliferation, 
and Ig production after toll-like receptor induction (  16, 17  ). 
Anti-DNA B cells (V  H  3H9) that are specifi  c for both double-
stranded DNA (dsDNA; 3H9   ×   V  k  4) or single-stranded DNA 
(ssDNA; 3H9   ×   V  k  8) are each limited in their secretion of 
DNA-specifi  c antibodies but vary for other functions. Al-
though the ssDNA-reactive B cells have a relatively normal 
response to BCR cross-linking, the dsDNA-reactive B cells 
are unresponsive, they have limited proliferation responses, 
and they are blocked in development at the immature B cell 
stage (  18  –  20  ). Intriguingly, a diff  erent anti-ssDNA transgenic 
mouse model (Ars/A1) is developmentally arrested at the T3 
stage and has reduced BCR signaling, no proliferation, and no 
antibody secretion upon BCR cross-linking (  13, 21  ). Trans-
genic B cells binding Smith (Sm) antigen are fairly normal but 
they only proliferate weakly and do not become fully mature 
plasma cells (  22  ). Finally, in humans, B cells with natural au-
toreactivity for polylactosamine chains (the 9G4 idiotype) are 
excluded from normal B cell responses (  23  –  25  ) and have 
attenuated BCR signaling capacity but appear to function 
normally in lupus patients (  26  ). However, because natural 
autoreactivity is diffi   cult to detect, little is known about the 
fate and phenotype of most autoreactive B cells in humans. 
  In this paper, we describe a population of naive-like human 
B cells that do not express IgM, only IgD (B  ND   cells for 
short). Analysis of recombinant monoclonal antibodies dem-
onstrated that most B  ND   cells are autoreactive, binding antigens 
on human HEp-2 cells or DNA. The autoreactivity occurs 
naturally, as the cells have completely germline (unmutated) 
variable genes and are fully mature by all measures. We sus-
pected that the autoreactive receptors of B  ND   cells might lead 
to chronic stimulation and induction of anergy. Indeed, based 
on analysis of calcium fl  ux and phosphorylated tyrosine 
(pTyr) levels after BCR cross-linkage, B  ND   cells are function-
ally attenuated. Because B  ND   cells can be fully activated by 
suffi   cient stimulation, we propose that these cells may be the 
    Figure 1.         B  ND   cells are gated as the IgD  +  IgM       CD27        cell fraction.  
Peripheral blood B cells (CD19  +  ) from humans are separated according to 
expression of IgM and IgD and then can be further distinguished by the 
CD27 expression that is found on memory B cells and plasma cells. On 
average, 3% of all B cells are found in the IgD-only fraction (gate I) where 
we fi  nd B  ND   cells (2.5%), which can be further distinguished from another 
IgD-only population in blood, C    -CS cells (0.5%), by CD27 expression. 
Naive B cells, representing the bulk of peripheral blood B cells (58%), are 
found in the double-positive fraction (gate II) and can be further sepa-
rated from IgD  + ,  IgM +  , memory, or marginal zone (MZ) cells by CD27 ex-
pression. The remaining fractions (IgM only and double negative) 
represent IgM memory and class-switched memory B cells, respectively, 
and are CD27  +  . All population percentages shown here represent the av-
erages from analysis of 40 healthy adult blood donors.     JEM VOL. 206, January 19, 2009 
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two well characterized antibodies that are used commonly to 
study anti-DNA reactivity (  Fig. 2 A  , red lines), including 3H9 
(  Fig. 2 A  , squares) (  2  ), and HN241 (  Fig. 2 A  , triangles) (  29  ).   
Anti-DNA binding affi   nity was determined by regression 
analysis of the binding curves (see Materials and methods). 
The positive control antibody 3H9 was used to normalize all 
frequently than naive B cells in a relative comparison. The fre-
quency of anti-DNA antibodies produced from naive versus 
B  ND   cells was evaluated by ELISA. Antibodies were expressed 
from 87 naive B cells (  n   = 16, 37, 10, 10, and 14 by donor) 
and from 95 B  ND   cells (  n   = 17, 21, 30, and 27 by donor). For 
comparison, we also expressed the variable genes encoding 
    Figure 2.         B  ND   cells express autoreactive antibodies.   Recombinant monoclonal antibodies were expressed by transfection of human 293 cells with 
the variable genes from single B  ND   (totaling 95 clones;   n   = 17, 21, 30, and 27) or naive B cells (totaling 87 clones;   n   = 16, 37, 10, 10, and 14 by donor) and 
tested for binding to dsDNA and to antigens within the human HEp-2 cell line. (A) ELISA analysis to determine the frequency of B  ND   and naive B cells that 
bind to dsDNA. The variable genes encoding classical anti-DNA antibodies were also added (red lines), including 3H9 (squares) (  2  ), and HN241 (triangles) 
(  29  ). Both control antibodies were expressed as chimeric mouse/human IgG-     recombinant monoclonals identically to the naive and B  ND   antibodies  so 
that all capture and detection reagents used were identical. Absorbencies were measured at OD  415   (y axis) and normalized to the 3H9-positive control 
antibody included on every plate. Binding to DNA is plotted for the various antibodies at 1   μ  g/ml (6.67 nM) and three additional fourfold serial dilutions 
(x axis indicates nanomoles). Saturation curves were used to calculate relative affi  nities to determine if antibodies were positively reactive. (B) ELISA 
screens were performed to determine the amount of ANA reactivity. The B  ND   and naive monoclonal antibodies from A were loaded at a concentration of 
25   μ  g/ml onto commercially available ANA antigen ELISA plates. Absorbencies were measured at OD  415   and compared and normalized to an in house posi-
tive clone, C    -CS clone B09 (  25  ). The absorbencies of naive versus B  ND   clones were signifi  cant by either Student  ’  s   t   test to compare means or Mann-Whit-
ney to compare the medians (P   <   0.0001 for either test; median absorbancies are indicated as red lines). (C) Antibody absorbencies from B averaged and 
compared by donor for naive population and B  ND   population, including three matched comparisons of naive versus B  ND   antibodies indicated with dotted 
lines. The B  ND   cells were more often ANA reactive on average between donors (P   <   0.02 by Student  ’  s   t   test with Welch  ’  s correction for unequal variance 
and P = 0.016 by Mann-Whitney test in comparing the medians). (D) HEp-2 reactivity was verifi  ed using immunofl  uorescence. Of the 95 antibodies de-
rived from B  ND   cells, 72 (75%) were clearly reactive with human HEp-2 cells. 20/87 (23%) of the antibodies from naive cells were HEp-2 reactive. Repre-
sentative antigen binding patterns on HEp-2 slides for antibodies from B  ND   cells are shown. Signifi  cance was established by     2 analysis; P   <   0.0001. 
Commercial HEp-2 slides were stained with recombinant monoclonal antibodies and with antihuman IgG-FITC secondary antibody and visualized using 
fl  uorescence microscopy. Bar, 20   μ  m.     142 AN ANERGIC B CELL SUBSET FROM HUMANS   | Duty et al. 
MitoTracker Green (MTG) (  34  ). Like naive cells, B  ND   cells 
actively extrude MTG, further demonstrating that they are 
neither transitional B cells nor are they memory cells (  Fig. 3 A  , 
middle). Finally, B  ND   cells do not produce CD179a (surro-
gate light chain; VpreB) transcripts, which distinguishes them 
from an autoreactive population of naive B cells that are in 
the process of receptor editing (  35, 36  ) (  Fig. 3 A  , bottom). 
  Besides IgD expression, B  ND   cells also express other mol-
ecules found only on mature circulating B cells including 
CD23, CD44, and CD40 (  Fig. 3 B  ). Lack of CD38 also dis-
tinguishes B  ND   cells from germinal center and plasma cells. 
Furthermore, like naive cells, B  ND   cells are not proliferating 
(CD71       ) and express neither the T cell costimulatory molecule 
CD80 nor the programmed cell death receptor CD95 (Fas), 
which are found on germinal center and memory B cells 
(  Fig. 3 C  ). Finally, like naive cells, most B  ND   cells express little 
CD5 protein (  Fig. 3 B  ) but, interestingly, included some cells 
that were CD5  low  , which is consistent with previous reports 
that CD5 expression is heterogeneous for various human B 
cell subsets (  37  ). CD5 expression in mice marks the B1a sub-
set of innate B cells and is known to be involved in negative 
regulation (  38  ). The distinction of CD5 as a lineage marker is 
not established for human B cell populations, but it has been 
proposed to be a marker of activation (  39  ). Although a con-
nection of B  ND   cells to a B1 cell type can  ’  t be completely 
ruled out, we conclude that in addition to autoreactive BCRs, 
B  ND   cells are mature resting B cells that are most similar to 
naive B cells. 
  B  ND   cells are naturally autoreactive, having no evidence 
of previous immune experience 
  Activated B cells rapidly proliferate and accumulate somatic 
mutations in the antibody variable genes to hone the specifi  c-
ity of the BCR. The cells also undergo class switch recombi-
nation to alter the antibody isotype. Variable regions from 
228 gene sequences were analyzed from B  ND   cells of nine 
blood donors and compared with historical data in the labo-
ratory from various other B cell subpopulations (  24, 25, 40  –
  42  ). B  ND   cells were analyzed from the four donors that 
antibodies were derived plus an additional fi  ve blood donors. 
As indicated in   Fig. 4 A  , there were no somatic mutations on 
the B  ND   cell variable genes, indicating that the autoreactivity 
detected is natural and not generated during an immune 
response.   In addition, no two B  ND   cells sharing the same VDJ 
junctions were detected, likely indicating that they have not 
been clonally expanded. Finally, there is a small population of 
germinal center, memory, and plasma cells that have class 
switched to IgD at the genetic level (referred to as C    -CS) 
and so are also IgD  +  IgM        (  43, 44  ). These cells also express 
autoreactive IgD receptors (  25  ). However, PCR analysis found 
no evidence of recombination junctions between the      and 
     switch regions for B  ND   cells (  Fig. 4 B  ), indicating that IgD 
is expressed as a splice product of VDJ-C    -C     transcripts and 
that B  ND   cells have not undergone class switch recombina-
tion. C    -CS B cells also have excessive somatic mutations of 
the variable genes and use predominantly Ig     light chains, 
ELISA plates. Antibodies with B  MAX   absorbencies that were 
greater than the 95% confi  dence interval of the low positive 
control (HN241) and had measured affi   nities of   >  7 nM (half-
maximal binding at     1   μ  g/ml) were scored as DNA binding. 
As indicated, of 95 antibodies from B  ND   cells, 16% bound ds-
DNA, which is nearly fourfold more frequent than antibodies 
from the 87 naive cells, of which 4.4% bound dsDNA. The 
frequency of naive cells binding DNA was also similar to that 
reported previously by Wardemann et al. (  1  ), whereas B  ND 
  cells bound DNA at a frequency similar to that of early 
immature B cells before B cell selection. Analysis of insulin 
or LPS binding by ELISA found that although DNA-binding 
antibodies from naive cells are often polyreactive, only half of 
the B  ND   cell  –  derived antibodies were polyreactive, and the re-
mainder bound only DNA (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20080611/DC1). 
  Analysis of sera antibodies for binding to HEp-2 cells de-
tected by indirect immunofl  uorescence is a classical test of au-
toreactivity. This antinuclear antibody (ANA) test is commonly 
used to assist with diagnosis of autoimmune diseases such as 
SLE (  31  ). Three-quarters (72/95 or 75%) of the antibodies de-
rived from B  ND   cells were clearly reactive with human HEp-2 
cells (  Fig. 2 D  , left). In contrast, consistent with previous re-
ports (  1, 25  ), only 23% (20 of 87) of the antibodies from naive 
cells bound to HEp-2 antigens (P   <   0.0001 by       2  ;   Fig. 2 D  , 
left). The HEp-2 binding patterns detected were quite vari-
able, indicating a variety of autoreactivities, but, notably, the 
majority of B  ND   cell antibodies bound to cytoplasmic antigens 
(  Fig. 2 D  , right). In addition, a quantitative assessment of the 
HEp-2 reactivity was determined using commercial ELISA-
based ANA kits (  Fig. 2 B  ). These assays demonstrated that 
ANA binding was signifi  cantly higher in the B  ND   population 
compared with the naive cell antibodies both when mean or 
median binding is assessed for all antibodies (P   <   0.0001 for ei-
ther Student  ’  s   t   test or Mann-Whitney test;   Fig. 2 B  ) and when 
compared between donors (P   <   0.02 by Student  ’  s   t   test with 
Welch  ’  s correction for unequal variance and P = 0.016 by 
Mann-Whitney test;  Fig. 2 C ). In conclusion, unlike IgM  +  IgD  +   
naive B cells, most B  ND   cells express autoreactive Igs. 
  B  ND   cells are mature naive-like B cells 
  As immature B cells before completing primary selection may 
be autoreactive, we hypothesize that B  ND   cells might be im-
mature. However, B  ND   cells do not express markers found on 
immature B cells such as the B cell progenitor marker CD10 
and, like mature cells, express only low levels of the develop-
ment markers CD38 and CD24, which are commonly used 
to distinguish recent BM immigrant immature/transitional 
B cells that are CD38  hi  CD24  hi   (  Fig. 3 A  ) (  32  ).   Furthermore, the 
B  ND   and naive populations are both positive for the BCR-as-
sociated regulator CD22 that is expressed on mature B cells 
(  33  ). In addition, recent reports have demonstrated that tran-
sitional B cells, as well as CD27  +   IgG  +   memory cells, in cir-
culation can be distinguished because they do not express the 
ATP binding cassette ABCB1 transporter and, subsequently, 
they retain mitochondrial dyes such as Rhodamine 123 or JEM VOL. 206, January 19, 2009 
ARTICLE
143
  B  ND   cells display reduced mobilization of intracellular 
calcium after BCR cross-linkage 
  In mouse models, self-reactive B cells that constitutively bind 
autoantigens become anergic, resulting in diminished down-
stream signaling events upon BCR cross-linkage (  11, 48  –  50  ). 
We hypothesized that the B  ND   cell population would also 
exhibit reduced signaling capacity upon activation because 
they are autoreactive. Immediately detectable measurements 
of BCR signaling that are reduced in anergic B cells of mice 
include the degree of intracellular calcium fl  ux and an overall 
decreased level of pTyr. To avoid prematurely stimulating 
the B cells, thus depleting calcium stores and aff  ecting pTyr 
levels, a negative enrichment scheme was used to isolate the 
further distinguishing them from B  ND   cells (  Fig. 4 A  ). Inter-
estingly, further indicating an autoreactive phenotype (  1, 24, 
35  ), B  ND   cells use predominantly J  H  6 gene segments to en-
code antibodies (  Fig. 4 C  ). In addition, variable genes from 
B cells of humans with lupus and in mouse models of lupus 
(mrl/lpr mice) tend to have long CDR segments (  45  –  47  ). 
Cells with long CDR3s are also counterselected during nor-
mal human B cell development (  1  ). As indicated in   Fig. 4  , 
both the frequency of B  ND   cells with long CDR3 segments 
(  Fig. 4 D  ) and the mean CDR3 length (  Fig. 4 E  ) is signifi  -
cantly increased for B  ND   cells. In conclusion, B  ND   cells are 
naturally autoreactive with no evidence of ever having been 
involved in an immune response. 
    Figure 3.         The B  ND   phenotype is naive mature B cells  . Peripheral blood B cells were isolated and stained with anti-CD19, CD27, IgM, and IgD, as well 
as one of each of the antibodies shown in the fi  gure, to delineate phenotype differences between B  ND   and naive populations for immaturity (A), maturity 
(B), or activation markers (C). Isotype controls were included and, where appropriate, CD19  +   human BM, marginal zone  –  like peripheral blood B cells 
(CD19  + ,  CD27 + ,  IgM +  , and IgD  +  ), or fractions representing IgG memory B cells (CD27  + ,  IgM      , and IgD       ) were included for an internal positive and negative 
control. Histograms are representative of three to eight donors in at least three independent experiments. RT-PCR analysis was performed on sorted B  ND  
and naive cells for the presence of VpreB (CD179a) transcripts. Actin RT-PCR was included as a template control.     144 AN ANERGIC B CELL SUBSET FROM HUMANS   | Duty et al. 
to most accurately mimic physiological stimulation with anti-
gen, we fi  rst used combined anti-IgM plus anti-IgD cross-link-
age to stimulate the B cells. Upon anti-IgD/IgM stimulation, 
the B  ND   population showed a dramatically decreased ability 
to fl  ux intracellular calcium compared with a substantial bipha-
sic fl  ux from the naive population (  Fig. 5 B  ). In comparison, 
the B  ND   population gave a result similar to CD27  +  IgM/D/
G        B cell (class switched) memory population representing 
both IgA and IgE memory cells, which, as predicted, do not 
B  ND   and control B cell populations. In brief, B  ND   and naive 
B cells were enriched by diff  erentially staining peripheral 
blood CD27        B cells loaded with the calcium dye Fluo-4 ei-
ther in the presence or absence of anti-IgM so that we could 
identify B  ND   or naive cells, respectively (  Fig. 5 A   and Materi-
als and methods).   Baseline intracellular calcium levels were 
established for 30 s, followed by treatment with various anti-
BCR antibodies. Physiologically, antigen should bind all sur-
face Ig regardless of isotype (i.e., IgD versus IgM). Therefore, 
    Figure 4.         The variable region sequences suggest that B  ND   cells are most like naive cells  . (A) Sequence analysis from several healthy donors of 
B  ND  , naive, IgG and IgM memory, and C    -CS (C-delta class switch) revealed that B  ND   cells, like naive cells, did not have somatic mutations in the variable 
region, are not clonally related as determined by common CDR3s, and use predominantly      light chains. (B) PCR of genomic DNA for the constant chain 
switch regions between      and      revealed no DNA recombination at the delta locus and, thus, the B  ND   cells are not class switched to DNA at the genomic 
level. (C) Comparison of heavy chain sequences for mean (  ±  SD) J  H   gene segment usage revealed increase use of J  H  6 (red bars) in B  ND   cells compared with 
J  H  6 usage in naive, IgM, and IgG populations (P   <   0.001 by Student  ’  s   t   test between the B  ND   J H  6 and separately J  H  6 in naive, IgM, and IgG populations; 
  n   values listed under the table in A). (D and E) B  ND   cells had more amino acids on average (  ±  SD) in their CDR3s as determined both by the frequency of 
cells with long CDR3s (17 aa  +  ; red bars; P   <   0.03) and the mean CDR3 length for each donor (points) and averaged for all donors (blue bars) as compared 
with the other blood B cell populations (E; P   <   0.05; scale is amino acids   >  10).     JEM VOL. 206, January 19, 2009 
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(  Fig. 5 E  ; P   <   0.05 by Student  ’  s   t   test). Similarly, BCR cross-
linking with anti-    /     resulted in reduced B  ND   calcium fl  ux 
(Fig. S2 B, available at http://www.jem.org/cgi/content/
full/jem.20080611/DC1). This diff  erence was not caused by 
a variegated uptake of the calcium dye Fluo-4 or reduced vi-
ability because calcium peaks between the B  ND   and naive 
populations were equal when treated with the ionophore 
ionomycin (  Fig. 5 D  ). 
respond to anti-IgD/IgM stimulation. Representative kinetic 
graphs are shown for 25   μ  g/ml of anti-IgM/D stimulant, rep-
resenting three separate donors. Similar trends were also ob-
served when various amounts of stimulant ranging from 
10  –  50   μ  g/ml were used, representing eight donors in three 
independent trials. On average, the peak mean fl  uorescence 
of Flou-4 was signifi  cantly higher for naive versus B  ND  , which 
is indicative of a more robust fl  ux of intracellular calcium 
    Figure 5.         B  ND   cells have attenuated calcium responses compared with naive cells after BCR cross-linking  . (A) A representative scheme of 
isolation and negative enrichment for the B  ND   and naive populations. Negatively enriched B cells from human peripheral blood were split into two equal 
fractions: one stained with anti-CD27, anti-IgM, and anti-IgG (anti-BCR) to negatively gate B  ND   cells and the other with anti-CD27 and anti-IgG (anti-BCR) to 
negatively gate naive cells. Cells were loaded with calcium dye Fluo-4 (Invitrogen) and transferred to fl  ow cytometer, warmed to 37  °  C, and treated with 
different amounts and combinations of polyclonal Fab  ’  2 BCR cross-linkers. Side stains were performed with these antibodies plus anti-CD19 and anti-IgD 
to test for population purity. In each case, B cell purities were   >  98% and B  ND   and naive purities were   >  96% as indicated. Calcium curves were determined 
using average mean fl  uorescence intensity (MFI) over time. (B) Representative kinetic graphs of average Flou-4 MFI over time for naive, B  ND  , and a B cell 
class-switched memory control (CS B cell) population representing IgA/E  +   memory cells (CD27  + ,  IgM     ,  IgG      , and IgD       ; black line). Basal levels were estab-
lished for 30 s and then the cells were treated with 50   μ  g/ml of anti-IgM Fab  ’  2/anti-IgD Fab  ’  2, 50   μ  g/ml of anti-IgD Fab  ’  2 alone (C), or 20   μ  g/ml ionomy-
cin (D). (E) Maximal peak fl  uorescence of Fluo-4 was averaged   ±  SD for B and C (*, P   <   0.05;   n   = 3 donors; Student  ’  s   t   test). (F) Mean fl  uorescence of 
Fluo-4   ±  SD representing the basal levels (the fi  rst 30 s) was calculated showing a slightly higher amount in the B  ND   population.   146 AN ANERGIC B CELL SUBSET FROM HUMANS   | Duty et al. 
  On average, from multiple blood samples, B  ND   cells 
accumulated signifi  cantly less total tyrosine phosphoryla-
tion than naive cells at various anti-IgD/IgM concentrations 
(  Fig. 6 B  ; signifi  cance for 10 and 50   μ  g/ml is P   <   0.05 and 
0.01, respectively by Student  ’  s   t   test). Each point in   Fig. 6 B   
represents the mean and SD for at least three independent 
analyses of B  ND   or naive cells pooled from at least three dif-
ferent donors for each repetition. As with calcium, treatment 
with anti-IgD alone also caused greater reduction in pTyr in-
duction in B  ND   cells than in naive B cells for each of three 
trials (  Fig. 6 C  ). The red, green, and blue lines represent the 
cells from independent blood donors simultaneously assayed 
for anti-IgD alone (  Fig. 6 C  , left) or in combination with 
anti-IgM (  Fig. 6 C  , right). More specifi  cally, Src family tyro-
sine kinases (Lyn, Fyn, and Blk), which are known to be im-
portant for transducing signals directly associated with 
receptor cross-linking, were evaluated for activation through 
detection of pTyr residue 416. Using calibration beads to es-
tablish absolute units, we found that in comparison to naive 
cells the B  ND   population had reduced pSrc levels upon treat-
ment with anti-IgD and anti-IgM (  Fig. 6 D  ; P   <   0.05 by 
Student  ’  s   t   test, based on three independent trials). In sum-
mary, pTyr levels were reduced for B  ND   cells after cross-link-
ing in every instance for 12 independent trials (totaling 30 
pooled blood donors). Interestingly, if B  ND   cells were rested 
overnight in culture, they phosphorylated tyrosines and fl  uxed 
calcium at similar levels as naive cells (Fig. S3 E, available at 
http://www.jem.org/cgi/content/full/jem.20080611/DC1), 
which is consistent with observations in transgenic mice where 
removal of the chronic self-stimulation rapidly allows return 
to a nonanergic state (  52  ). 
  In conclusion, likely because of chronic self-stimulation, 
B  ND   cells are anergic, displaying reduced activation levels after 
BCR cross-linkage. This analysis suggests that B  ND   cells have a 
decreased ability to respond to antigen binding, thus avoiding 
the eventual secretion of autoantibodies. Future characteriza-
tion of the specifi  c signaling pathways disrupted in B  ND   cells 
should provide insight into the intrinsic mechanisms of immune 
tolerance for B cells and may identify specifi  c pathways that can 
be therapeutically targeted to treat autoimmune diseases. 
    DISCUSSION   
  Mature and naive autoreactive (and thus potentially patho-
genic) B cells in the periphery have been shown to account for 
up to 20% of the circulating B cell pool in healthy human 
adults (  1, 25  ). The presence of these autoreactive cells begs 
many but ultimately two important questions: why have they 
survived selection and how are they tolerized? Focusing on 
the latter, extensive studies of self-tolerant B cells in transgenic 
mouse models over the last two decades have revealed the 
complicated systems of B cell selection used to avoid autoim-
munity. B cells expressing transgenic surface Ig that bind DNA 
or protein autoantigens that do not alter the BCR by receptor 
editing (  2, 3  ) may be eliminated (clonal deletion) (  4  ). Impor-
tantly, and pertinent to this work, many autoreactive cells pass 
these checkpoints for reasons not well understood and survive 
  One possibility was that the reduced calcium response 
was because the B  ND   population expresses only surface IgD 
whereas naive cells also express IgM (  Fig.1  ), thus resulting in 
diff  erent frequencies of BCR cross-linkage or in qualitative 
diff  erences in the signaling cascade. To gain functional in-
sight, the cells were stimulated with anti-IgD alone. Anti-
IgD alone also resulted in signifi  cantly less activation of the 
B  ND   than the naive population (  Fig. 5, D and E  ; P   <   0.05 by 
Student  ’  s   t   test). This indicates that the reduced signaling ca-
pacity in the B  ND   population was caused by an intrinsic over-
all reduction in receptor mediated signaling. 
  As reported for anergic B cells in mice (  48, 51  ; for review 
see reference   15  ), basal calcium levels for the B  ND   population 
were 10% higher on average than for naive cells, which is 
consistent with chronic stimulation by self-antigen (  Fig. 5 F  ). 
We conclude from these experiments that B  ND   cells have in-
trinsically attenuated BCR-induced calcium fl  ux and that this 
anergized phenotype likely results from chronic exposure to 
self-antigen in vivo. 
  B  ND   cells accumulate less pTyr when activated 
by BCR cross-linking 
  In addition to calcium fl  ux, the signaling cascade seconds and 
minutes after BCR cross-linkage results in overall increases of 
cellular pTyr levels. Because relatively few B  ND   cells can be 
isolated at any one time from human peripheral blood, we 
chose to analyze pTyr levels by using fl  ow cytometry or   “  Phos-
Flow.  ”   This powerful technique allows the quantifi  cation of 
both the pTyr magnitude for each individual cell and the fre-
quency of cells aff  ected. With this assay, total activated B cells 
are rapidly fi  xed seconds after receptor cross-linkage and 
before any manipulation that might reduce detectable pTyr 
levels. The phenotypes and pTyr levels of individual cells can 
then be resolved retrospectively by using immunostaining and 
detection on a fl  ow cytometer (  Fig. 6 A  ).   Each B cell popula-
tion was fractionated and depleted of other cell types. Naive 
and B  ND   cells were fi  rst enriched through sorting with anti-
CD27 and anti-IgM antibodies. Naive cells are predominantly 
in the total CD27        fraction, B  ND   cells are predominantly in the 
IgM       CD27        fraction, and untreated cells that will not be acti-
vated by anti-IgM/D treatment are predominantly in the 
CD27       IgD       IgM        fraction (determined separately to be mostly 
IgG, IgA, or IgE  +   B cells). By spiking the anti-IgM/IgD Fab    2 
cross-linking mix with a fl  uorescently labeled (FITC) anti-IgD 
and then staining with intracellular anti-CD20 and anti-pTyr 
after stimulation, fi  xation, and permeabilization, we could gate 
and resolve each B cell population to high purity (  Fig. 6 A  , 
left). As indicated in the middle of   Fig. 6 A  , poststimulation 
pTyr levels were much greater in naive B cells than in B  ND   
cells after treatment with a combination of polyclonal anti-
IgD/IgM for an optimal 45 s (determined separately to be the 
peak of activation; Fig. S2 A). The reduced pTyr induction is 
not caused by increased cell death or lack of viability in the 
B  ND   population, as both they and naive cells are stimulated to 
the same level with the phosphatase inhibitor pervanadate (or-
thovandate H  2  O  2  ;   Fig. 6 A  , right histogram). JEM VOL. 206, January 19, 2009 
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coveries of the past 20 yr concerning autoreactive B cells in 
transgenic mice to immune tolerance in humans. Through 
analyses of a mature naive human B cell population, we have 
shown that, similar to the classical anti-HEL/HEL model of 
to the periphery, but with reduced or altered function so they 
no longer react to the self-antigens (clonal anergy) (  7, 8  ). 
  A key advance to understanding and treating human au-
toimmune disease is to link the numerous fundamental dis-
    Figure 6.         B  ND   cells have reduced tyrosine phosphorylation, suggesting that they are natural anergic B cells.   (A) Representative histogram of 
treated B  ND   and naive cells sorted according to a least-touch strategy (see Materials and methods). 10  5   cells were incubated with anti-IgD Fab  ’  2-FITC + 
IgM  Fab ’  2   for 45 s at various concentrations, fi  xed, and permeabilized, followed by staining by anti-pTyr and intracellular anti-CD20. Histograms were 
built by FACS analysis and treated populations were compared with untreated controls. Cells were also stimulated with pervanadate as a positive control 
(right histogram). Green lines are used as qualitative references to mark the median fl  uorescence of the untreated controls, allowing a visual comparison 
of fl  uorescence shift with treated samples. (B) Cells were stimulated with anti-IgD Fab  ’  2 FITC + IgM Fab  ’    2   at concentrations of 10, 50, and 100   μ  g/ml to 
determine concentration dependency and were plotted as mean fl  uorescence intensity (MFI)   ±   SD of pTyr-PE (for each concentration point,   n   = 3 groups 
of 1  –  3 donors; *, P   <   0.05 and **, P   <   0.01 for 10 and 50   μ  g/ml, respectively, by Student  ’  s   t   test). Class switched B cells could also be gated (IgD      ,  IgM     , 
and CD20  +  ; black line) from the peripheral set and are included as an internal negative control. Isotype controls (gray line) were established for the stimu-
lated fractions. (C) Incubation of B  ND   and naive cells with 50   μ  g/ml of anti-IgD Fab  ’    2   alone or in combination with anti-IgM. Results of three donors are 
plotted as MFI of pTyr. Error bars represent the mean   ±   SD. Color lines represent individual donor variation between naive and B  ND   population. (D) Cells 
were sorted as in A but stained with antiphosphorylated Src (pTyr 416; pSrc). Representative histograms are shown for naive and B  ND   cells, untreated and 
treated with anti-IgD Fab  ’  2 FITC + anti-IgM Fab  ’  2. Bar graphs represent the mean absolute number of units/molecules   ±  SD of phosphorylated Src as de-
termined by Sphero Rainbow Calibration beads (Invitrogen) from three healthy donors and compared between B  ND   (red) and naive (blue) populations for 
both treated and untreated fractions. Signifi  cance for treated fractions (P   <   0.05) was established by a Student  ’  s   t   test.   148 AN ANERGIC B CELL SUBSET FROM HUMANS   | Duty et al. 
marker CD71, and diff  erentiate into plasmablast-like CD-
38  hi  CD27  hi   cells (Fig. S3). Thus, as in previous reports (  52, 
54, 55  ), anergy in the B  ND   population appears transient and 
reversible if the cells receive appropriate pro-T/B cell signals 
or if the cells are removed from the autoreactive environ-
ment. Importantly, Chang et al. (  56  ) recently found that 
IgD  +  IgM  low  CD27        B cells that we suspect are B  ND   cells be-
come increased in SLE patients. Unlike healthy people, in 
SLE patients these cells also displayed evidence of activation 
such as up-regulated CD80/86 levels. Thus, B  ND   cells may 
pose a serious danger in the development of acute or chronic 
autoimmune pathology, especially if T cell tolerance is also 
breached allowing helper activation of these autoreactive 
cells. We propose that the B  ND   population may be an important 
source of precursors for pathological autoantibody-secreting 
cells activated in lupus or other autoimmune diseases. 
  In conclusion, we have characterized a population of 
naturally autoreactive B cells in humans that have become 
anergic. We can now study the molecular and functional char-
acteristics of this manifestation of anergy and its role in avoid-
ing autoimmunity, or if these cells are not properly controlled, 
in causing autoimmune disease. Further, studies to elucidate 
the mechanisms inducing anergy may identify molecular 
pathways that can be exploited pharmacologically to induce 
an anergic state in reactive B cells to treat autoimmune dis-
eases or avoid organ rejection. 
  MATERIALS AND METHODS 
  B cell enrichment, sorting, and FACS analyses.     B lymphocytes were 
isolated from the buff  y coat component from 500 ml of freshly donated 
peripheral human blood obtained from the Oklahoma Blood Institute 
(Oklahoma City, OK) according to established National Institutes of Health 
guidelines and protocols with approval from the Oklahoma Medical research 
Foundation Institutional Review Board. Lymphocytes were isolated by 
placement over a Ficoll density gradient to remove RBCs and other leuko-
cytes followed by B cell  –  specifi  c enrichment by negative magnetic bead se-
lection as described previously (  24, 40, 57  ). Cell sorting was performed by 
staining the cells with monoclonal antihuman antibodies against CD27-
FITC, CD19-PE  –  Alexa Fluor 610 (Invitrogen), IgM-APC (SouthernBio-
tech), and IgD-PE (BD). B  ND   and naive B cell populations were resolved as 
in   Fig. 1   using a MoFlo fl  ow cytometer (Dako) in the Oklahoma Medical 
Research Foundation fl  ow core facility. For phenotype profi  les, populations 
were resolved as in   Fig. 1   and stained with various antihuman antibodies la-
beled with either FITC or PE fl  uorophores (Invitrogen), including mono-
clonal antibodies against CD38, CD44, CD80, CD71, CD95, CD138, 
CD5, CD179a, CD23, CD21, and Annexin-V. For analyses of mitochon-
drial dye retention, MTG FM dye (Invitrogen) was loaded into sorted B  ND   
and naive B cell populations at a concentration of 100 nM for 30 min and 
chased with fresh media as previously described (  34  ). For single-cell PCR, 
bulk cells of either phenotype were fi  rst sorted and then resorted into 96-
well PCR plates to ensure purity of single cells (98  –  99% pure). FACS analy-
sis was performed using fl   ow core facility FACSCalibur, FACSAria, or 
LSR-II fl  ow cytometers (BD) and software analysis was performed with 
FlowJo Cytometric software (Tree Star, Inc.). 
  Sequencing and repertoire analysis.     Cells were sorted into the diff  erent 
populations as indicated above and as previously described (  24, 40, 57  ). V re-
gion amplifi  cation and sequence analysis was performed as described but, in 
brief, VH4 and VH3 family specifi  c leader sense primers were paired with 
antisense primers to particular constant region gene (     or     ). These primers 
anergy developed by Goodnow (  8  ), IgD  +   B cells with no 
surface IgM are predominantly autoreactive and are functionally 
attenuated. The mechanistic connection between anergy and 
reduced IgM expression is not known and is not a universal 
phenotype of all anergic B cells (for review see reference   15  ) 
but may represent a consequence of constant self-antigen ex-
posure in the early life of the cell (  53  ). 
  As described, anergy in the B  ND   population is not solely 
dependent on receptor density (or lack of surface IgM ex-
pression), as signaling through IgD alone was also less eff  ec-
tive for B  ND   than for naive cells (  Fig. 5   &   6  ). However, it is 
notable that naive cells responded diff  erently to cross-linking 
by IgM versus IgD, suggesting that down-regulation of sur-
face IgM could have functional consequences for the B  ND   
cells. Though the initial burst of stimulation was similar with 
either cross-linking reagent, a subsequent plateau of sustained 
increased calcium levels was maintained after IgM stimula-
tion but was lost after IgD stimulation (Fig. S2 C). Combined 
stimulation through both IgM and IgD resulted in an additive 
response, with an initial burst similar to either reagent alone, 
followed by a plateau of sustained calcium levels similar to 
the anti-IgM response. Thus, assuming that the anti-IgD and 
anti-IgM reagents similarly cross-link their respective target 
epitopes, the maintenance of anergy in B  ND   cells may also be 
infl  uenced by the lack of surface IgM. The exact mechanism 
behind the receptor-mediated lack of response in the B  ND   
population will need to be further elucidated. 
  B  ND   cells exhibit a well-characterized naive phenotype in 
that they are CD44  +  , CD23  +  , CD38       , CD95       , CD80       , and 
CD5       . They were not clonally expanded and had no somatic 
mutations. Importantly, B  ND   cells can also be distinguished from 
immature new BM immigrant B cells described in recent re-
ports (  1, 32  ) because the immature cells are CD44        and CD38  +   
as well as being IgD        and IgM  +  . B  ND   cells also do not express 
surrogate light chains (CD179a), distinguishing them from preB 
cells, editing B cells, or recent bone emigrants from the BM 
(  35, 36  ). Thus, B  ND   cells appear mature by all measures; how-
ever, we cannot rule out the possibility that they have recently 
transitioned from an immature state. Similarly, although the 
attenuated signaling of B  ND   cells demonstrated that these cells 
are anergic, we cannot completely rule out some specialized 
B cell diff  erentiation similar to B1 or MZ cells in mice be-
cause these populations have not been well established in hu-
mans. However, based on all analyses to date we propose that 
B  ND   cells arise from autoreactive naive cells that have ma-
tured in the classical B-2 pathway. 
  Similarly to previous reports of anergy, B  ND   cells show 
attenuation in Ca  2+   response and a decrease in accumulation 
of phosphotyrosines upon treatment with BCR cross-linkers. 
However, much like anergic B cells in mice, an active mech-
anism and exposure to autoantigen appears necessary to main-
tain anergy because rest in tissue culture media overnight 
restores B  ND   cell signaling to levels similar to naive cells (Fig. S3). 
In addition, the function of B  ND   cells can be rescued when 
treated with the soluble T cell factors Il-4 and CD40L, lead-
ing them to proliferate, express CD80 and the proliferation JEM VOL. 206, January 19, 2009 
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were warmed to 30  °  C for 10 min. After temperature equilibration, cells 
were loaded with Fluo-4 AM calcium indicator (Invitrogen) at a fi  nal con-
centration of 5   μ  M and incubated for 15 min in the dark. Cells were then 
washed and resuspended in HBSS/BSA containing 2.5   μ  M Probenecid 
(Sigma-Aldrich) for an additional 30 min at 30  °  C. After calcium dye loading, 
cells were placed on ice and diff  erentially stained for 30 min. The naive frac-
tions, including ionomycin naive, received anti-CD27 PE (Invitrogen) and 
anti  –  IgG-APC (BD) antibodies. The B  ND   fractions, including ionomycin 
B  ND  , received anti-CD27 PE, anti  –  IgM-APC, and anti  –  IgG-APC. Cells were 
also stained with anti  –  CD3-Bio and streptavidin-PE (Invitrogen) to gate out 
T cells and other non-B cells that escaped column purifi  cation. Non  –  Fluo-
4-loaded B cells from each donor were also simultaneously stained, but with 
the addition of anti-IgD to evaluate the purity of measured fractions. After 
staining, cells were washed in HBSS/BSA/Probenecid and placed at 37  °  C 
for 10 min. Cells were then placed on a LSRII fl  ow cytometer and gates 
were drawn for the subpopulations naive and B  ND  . Baselines were read for 
30 s, after which the cells were removed and stimulated with indicated 
amounts of Fab    2 anti-IgM (Jackson ImmunoResearch Laboratories) and 
Fab    2 anti-IgD (SouthernBiotech) or Fab    2 anti-IgD alone or Fab    2 anti-
    /     (SouthernBiotech) antibodies. Calcium curves were read for 5  –  7 min. 
In the ionomycin fractions, 5   μ  l of 1 mg/ml ionomycin/EtOH (Sigma-
Aldrich) was added 30 s after baseline reads to control for dye loading and 
cell activation potential. Kinetic curves for each calcium response were gen-
erated using FlowJo software. 
  PhosFlow analysis.     Human B cells from blood buff  y coats were isolated 
(see B cell enrichment, sorting, and FACS analysis) and split into two pools 
for sorting, one (pool 1) stained with anti  –  CD27-FITC and the other (pool 
2) with anti  –  CD27-FITC and anti  –  IgM-APC. Pool 1 B cells were sorted for 
CD27-negative cells and represented primarily naive cells. Pool 2 cells, rep-
resenting the B  ND   cells, were sorted for the IgM       CD27        population. Each 
pool was then washed and resuspended in RPMI without FCS and pre-
heated to 37  °  C. The cells were then split into aliquots (10  5   cells/tube) and 
incubated for 45 s with polyclonal anti-IgD Fab 2    -FITC (SouthernBiotech) 
and polyclonal anti-IgM Fab 2     (Jackson ImmunoResearch Laboratories). 
Cells were then immediately fi  xed with PhosFlow Fix Buff  er I (BD) for 
10 min at 37  °  C. Cells were then washed two times in PhosFlow Perm/Wash 
Buff  er I (BD), and stained with anti  –  pTyr-PE (clone PY20; BD) or an-
tiphosphorylated Src (phosphorylated Tyr 416; Cell Signaling Technology). 
Cells were simultaneously stained with intracellular anti  –  CD20-PerCP-
Cy5.5 (clone H1-FB1; BD) at the amounts suggested by the manufacturer. 
For the pSrc analysis, Sphero Rainbow Beads (BD) were used at the amounts 
suggested by the manufacturer to calibrate the FACS machine for direct 
comparisons from multiple experiments. For a positive control, a separate 
fraction (10  5  ) of each population was incubated for 5 min with 5   μ  l of the 
protein tyrosine phosphatase inhibitor pervanadate/H  2  O  2   (3% 100 mM or-
thovanadate and 3% H  2  O  2   in dH  2  O). Populations were resolved using FACS 
and compared with an untreated control. All computational analysis was 
performed with FlowJo software. 
  Statistical analyses.     Graphing and statistical analysis were performed using 
Prism software (GraphPad Software, Inc.) or Excel (Microsoft). For com-
parisons of antibody autoreactivity between total naive and B  ND   antibodies 
the       2   statistic was used. To compare the ANA values generated by the ANA 
ELISA assays, we used both Student  ’  s   t   tests to compare the means and 
Mann-Whitney tests to compare the medians. The Student  ’  s   t   tests were 
done with a Welch  ’  s correction because of unequal variances between the 
naive and B  ND   datasets (determined by the F test). However, although not 
signifi  cantly so, there was a non-Gaussian distribution notable in these datas-
ets and, therefore, we also used the nonparametric Mann-Whitney test to 
compare the median distributions. Also, because of the non-Gaussian dis-
tribution the medians are noted in   Fig. 2   rather than the means. PhosFlow 
analyses of pTyr levels and variable gene repertoire analyses used two-
tailed Student  ’  s   t   tests (paired for PhosFlow analyses and heteroscedastic for 
the repertoire analyses). 
included the following: VH4 sense primer, 5    -ATGAAACACCTGTG-
GTTCTT-3    ; C     antisense primer, 5    -CACGTTCTTTTCTTTGTTGC-3    ; 
and C     antisense primer, 5    -GTGTCTGCACCCTGATATGATGG-3    . 
PCR products were amplifi  ed using TA or TOPO-TA cloning kits (Invit-
rogen), and plasmid purifi   cation was performed using the miniprep kit 
(QIAGEN). Sequencing was done at the Oklahoma Medical Research 
Foundation sequencing core. All V regions were analyzed using in house 
analysis software and the National Center for Biotechnology Information 
IgBlast server (http://www.ncbi.nlm.nih.gov/igblast/) or the Immuno-
genetics server (http://imgt.org/IMGT_vquest/share/textes/). 
  For VpreB (CD179a) analysis, RNA was extracted from 10  4    –  10  5   
freshly sorted B  ND   and naive fractions using RNAWiz (Ambion), followed 
by One-Step RT-PCR (QIAGEN) RNA to cDNA amplifi  cation in 40 
repeated cycles of equal RNA amounts, using the following primer sets: 
VpreB sense, 5    -GAGTCAGAGCTCTGCATGTCTG-3    ; VpreB antisense, 
5    -GTGAGGCCGGATTGTGGTTCCAAG-3    ; actin sense. 5    -TAC-
CACTGGCATCGTGATGGACT-3    ; and actin antisense, 5   -TCCTTCT-
GCATCCTGTCGGCAAT-3    . Direct PCR products were analyzed on 1% 
agarose gels with TAE buff  er. 
  Production of recombinant monoclonal antibodies from single hu-
man B cell.     In order to test the specifi  city of B  ND   cells, recombinant mono-
clonal antibodies were produced from the variable region genes of isolated 
single cells. Using a modifi  ed strategy similar to previous reports (  1, 25, 36  ), 
single B cells were sorted by fl  ow cytometry into 96-well plates, and the 
variable genes amplifi  ed by multiplex single-cell RT-PCR to identify and 
clone the Ig heavy and light chain genes from a random assortment of cells. 
These variable genes were then cloned into expression vectors and expressed 
with IgG constant regions in the 293A human cell line. A total of 95 anti-
bodies from B  ND   cells (  n   = 17, 21, 30, and 27 by donor) were compared with 
87 antibodies from naive B cells (IgD  +  IgM  +  CD38       ;   n   = 16, 37, 10, 10, and 
14 by donor). Three sets of naive and B  ND   antibodies were matched from 
individual donors. Each antibody was purifi  ed from the serum-free tissue 
culture media. 
  ELISA and HEp-2 analyses for autoreactivity.     To screen the expressed 
antibodies for DNA reactivity or polyreactivity, ELISA microtiter plates 
(Costar; Corning) were coated with 10   μ  g/ml of calf thymus ssDNA or ds-
DNA (Invitrogen), LPS (Sigma-Aldrich), or recombinant human insulin 
(Fitzgerald). Goat anti  –  human IgG (  	   chain specifi  c) peroxidase conjugate 
(Jackson ImmunoResearch Laboratories) was used to detect binding of the 
recombinant antibodies followed by development with horseradish peroxi-
dase substrate (Bio-Rad Laboratories). Absorbencies were measured at OD  415   
on a microplate reader (MDS Analytical Technologies). Antibody affi   nities 
to the various antigens were compared by endpoint regression analyses to 
predict the absorbencies expected based on the binding curve for four four-
fold dilutions of antibody (beginning at 1   μ  g/ml, 7 nM) against a fi  xed con-
centration of antigen. Antibodies with B  MAX   absorbencies that were above 
the 95% confi  dence interval of the low positive control (HN241) and had 
measured affi   nities of   <  7 nM (half-maximal binding at     1   μ  g/ml) were 
scored as DNA binding. All antibodies were screened for ANA reactivity 
using the QUANTA Lite ANA ELISA kit (INOVA Diagnostics, Inc.) as per 
the manufacturer  ’  s direction. ANA results were verifi  ed on a subset of anti-
bodies by immunofl  uorescence using commercial HEp-2 slides (Bion Enter-
prises) as previously described (  1, 36  ) and as per the manufacturer  ’  s suggested 
protocol. HEp-2 slides were analyzed using a fl  uorescent microscope (Axio-
plan II; Carl Zeiss, Inc.). All HEp-2 and ANA reactivity were compared 
with positive control sera from a lupus patient and to nonreactive sera from 
a healthy blood donor. 
  Calcium fl  ux.     Fresh human PBMCs from buff  y coats were enriched for 
B cells (see B cell enrichment, sorting, and FACS analysis) and split into four 
equal fractions of 10  6   cells for each donor (  1  ): naive (  2  ), B  ND   (  3  ), ionomycin 
naive (  4  ), and ionomycin B  ND  . Cells were resuspended in preprepared HBSS 
containing 1   μ  M Ca  2+  and 1   μ  M Mg  2+   ions supplemented with 1% BSA and 150 AN ANERGIC B CELL SUBSET FROM HUMANS   | Duty et al. 
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